ProfileGDS5822 / ILMN_2522055
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 12% 5% 11% 19% 22% 12% 5% 5% 21% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 110.812
GSM1276600PDAC Late Ablation Control 29.95
GSM1276601PDAC Late Ablation Control 33.811
GSM1276602PDAC Late Ablation 111.119
GSM1276603PDAC Late Ablation 212.722
GSM1276604PDAC Late Ablation 39.112
GSM1303940PDAC Late Ablation_anti-CTLA4 16.95
GSM1303941PDAC Late Ablation_anti-CTLA4 24.15
GSM1303942PDAC Late Ablation_anti-CTLA4 310.821